Site-directed mutagenesis has been used to remove 15 of the 18 potential N-linked glycosylation sites, in 16 combinations, from the human exon 11-minus receptor isoform. The three glycosylation sites not mutated were asparagine residues 25, 397 and 894, which are known to be important in receptor biosynthesis or function. The effects of these mutations on proreceptor processing into α and β subunits, cell-surface expression, insulin binding and receptor autophosphorylation were assessed in Chinese hamster ovary cells. The double mutants 16j78, 16j111, 16j215, 16j255, 337j418, the triple mutants 295j337j418, 295j418j514, 337j418j514 and 730j 743j881 and the quadruple mutants 606j730j743j881 and 671j730j743j881 seemed normal by all criteria examined. The triple mutant 16j215j255 showed only low levels of correctly processed receptor on the cell surface, this processed receptor being autophosphorylated in response to insulin. The quadruple mutant 624j730j743j881 showed normal pro-
INTRODUCTION
Glycosylation is a major source of molecular heterogeneity of glycoproteins in both composition and conformation, and can prevent the formation of the orderly crystal lattice necessary for structural analysis [1, 2] . Overcoming this problem is not straightforward because of the potential importance of attached carbohydrate for protein solubility and its critical role in glycoprotein biosynthesis. In mammalian cells the correct folding and oligomerization of complex, multidomain proteins is controlled by N-glycosylation [3] . Reversible trimming of newly synthesized Nglycosylated polypeptides by glucosidase and glucosyltransferase enzymes controls their transient association with the two lectin chaperones calnexin and calreticulin [3] . Binding to calnexin and calreticulin slows down the rate of folding and prevents the occurrence of premature associations before all protein domains have been synthesized. This reversible process of glucosylation\ lectin binding and deglucosylation\lectin release continues until the glycoprotein is correctly folded and assembled [3, 4] . Chaperone-mediated glycoprotein folding, including the effects of selectively removing specific glycosylation sites [4] , has been studied extensively with influenza virus haemagglutinin (HA) and has been investigated more recently with the human insulin receptor (hIR) [5] .
The hIR is a multidomain, dimeric, membrane-bound glycoprotein composed of two α chains and two β chains, the latter having a single membrane-spanning sequence [6] . The receptor is initially synthesized as a single-chain proreceptor, which is Abbreviations used : CHO, Chinese hamster ovary ; ER, endoplasmic reticulum ; FnIII, fibronectin type III ; HA, haemagglutinin ; hIR, human insulin receptor ; hIGF-1R, human insulin-like growth factor type 1 receptor ; hIRR, human insulin-receptor-related receptor ; mAb, monoclonal antibody. 1 To whom correspondence should be addressed (e-mail colin.ward!hsn.csiro.au).
cessing and ligand binding but exhibited a constitutively active tyrosine kinase as judged by autophosphorylation. Three higherorder mutants were constructed, two of which, 16j337j418 j730j743j881 (∆6) and 16j295j337j418j730j743 j881 (∆7a), seemed normal. The third construct, 16j337j418 j514j730j743j881 (∆7b), was expressed at high levels on the cell surface, essentially as uncleaved proreceptor with only the small proportion of ∆7b that was correctly processed showing insulin-stimulated autophosphorylation. The mutations of ∆6 and ∆7a were incorporated into soluble ectodomains, which had affinities for insulin that were 4-fold that of wild-type ectodomain. The ∆6 ectodomain expressed in Lec8 cells was produced in quantity in a bioreactor for subsequent structural analysis.
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glycosylated and proteolytically processed to α and β chains during transport to the cell surface [7] [8] [9] [10] . Each monomer in the extracellular region comprises an α chain (residues 1-719 or 731 depending on the isoform [11] ) and 194 residues of the β chain. Sequence analyses revealed that the ectodomain of each monomer contains seven domains : L1, Cys-rich, L2, three fibronectin type III (FnIII) modules and an insert domain of approx. 120-130 residues [12] [13] [14] [15] [16] [17] [18] [19] predicted to be located in the Ch-E loop [17] or the E-F loop [19, 20] of the second FnIII domain. The dimer disulphide bonds are located in the first FnIII module and the insert domain [21] . The hIR is heavily glycosylated and is estimated to contain 58-64 kDa of carbohydrate [22] . Oligosaccharides of both the high-mannose and complex type are present, the latter containing additional fucose, N-acetylglucosamine, galactose and sialic acid residues [6, 7, 23, 24] . The hIR has 18 potential sites for N-linked glycosylation, 14 on the α chain and 4 on the β chain, of which 16 have been confirmed as glycosylated (L. G. Sparrow, personal communication). O-linked glycosylation has been demonstrated only in the β subunit [23, 25, 26] . Other members of the insulin receptor family have fewer potential N-linked glycosylation sites, suggesting that not all sites are required for correct folding, assembly and function. As summarized in Figure 1 , the IGF human insulin-like growth factor type 1 receptor (hIGF-1R) has 16 potential N-linked glycosylation sites [27] , whereas the human insulin-receptor-related receptor (hIRR) has 11 sites [28] .
Simultaneous mutation (Asn Gln) of the four N-linked glycosylation sites (residues 742, 755, 893 and 906) in the β chain of the exon j11 isoform had no effect on hIR processing, intracellular transport or insulin binding but did have a deleterious effect on autophosphorylation and signal transduction [29] . In contrast, similar mutation of the four glycosylation sites (residues 16, 25, 78 and 111) in the L1 domain abolished proreceptor processing and intracellular transport to the plasma membrane [30] . However, glycosylation at all these sites was not required because single-site mutations at either residue 16 or 25 had little effect compared with the significant decrease in cell surface receptor levels when both residues 16 and 25 were mutated [31] . Similarly, glycosylation at either 397 or 418, but not at both sites, is required for normal receptor biosynthesis [32] .
To understand the requirements of N-linked glycosylation during hIR biosynthesis, we have used site-directed mutagenesis to remove the N-linked glycosylation sites at 15 positions in various combinations. The effects of these mutations on proreceptor processing into α and β subunits, cell surface expression, insulin binding and receptor autophosphorylation were measured. Mutants of hIR with six (∆6, N"' , $$(,%"),($!,(%$,))"Q) or seven (∆7a, S#*(N\N"' , $$(,%"),($!,(%$,))"Q) sites removed could be generated that appeared normal by all criteria. These mutated proteins were expressed as soluble, secreted ectodomains in Chinese hamster ovary (CHO)-K1 cells and Lec8 cells [33] and the ∆6 ectodomain was produced in large-scale fermentation for structural analyses and crystallization screens. Atomic-level structural information is required to understand the molecular mechanisms by which the binding of insulin to its receptor initiates signal transduction.
EXPERIMENTAL Mutagenesis
The DNA used in these studies was derived from a full-length hIR cDNA from plasmid peT [34] , in which the 1.8 kbp AatII fragment, which harbours exon 11, was exchanged for the equivalent fragment from an exon 11-minus partial hIR cDNA from plasmid pHIR\P12-1 [9] . Three fragments of hIR cDNA from this plasmid, peT\11 − , were introduced into M13mp18 [35] for mutagenesis : a 1.0 kbp EcoRI fragment, which included DNA encoding the N-terminal amino acid sequence from the signal peptide to amino acid residue 294 ; a 0.9 kbp EcoRI-BamHI fragment encoding residues 295-599 ; and a 2.7 kbp BamHI-XbaI fragment encoding the C-terminal sequence from residue 600. Oligonucleotide-directed mutagenesis of these fragments in itro with the USB-T7 Gen4 in itro mutagenesis kit was employed to remove 15 selected N-linked glycosylation sites by mutating asparagine residues 16, 78, 111, 215, 255, 337, 418, 514, 606, 624, 671, 730, 743 and 881 to glutamine and the serine residue at 297 to asparagine (see Figure  1 ). The mutation of S#*( in the consensus site for N#*& glycosylation was performed to avoid the destruction of an EcoRI site required for the later reinsertion of fragments. Clones incorporating the mutations were identified by colony hybridization [36] with $#P-labelled mutagenic oligonucleotide as a probe ; the mutations were confirmed by DNA sequence determination [37] .
A vehicle for the mammalian cell expression of hIR cDNA with which the mutated fragments could be exchanged was prepared from the expression vector pEE14 (Celltech Ltd., Slough, Bucks., U.K.) [38] modified by the deletion of EcoRI and BamHI restriction sites through fill-in and religation. The hIR cDNA for this construct was taken from plasmid peT\11 − (described above), which has two EcoRI sites : one in an upstream polylinker sequence, the other in the hIR cDNA sequence. The site in the polylinker was deleted by partial EcoRI digestion, fillin and religation to facilitate the subsequent exchange of fragments. The hIR cDNA from this plasmid, peT\11 − \∆EcoRI, was inserted into the polylinker of the modified pEE14 expression vector as a HindIII-XbaI fragment. Mutated DNA was introduced into the hIR cDNA of this vehicle by the exchange of a 0.94 kbp NotI-EcoRI fragment (encoding residues k18 to 294 of insulin receptor), the 0.9 kbp EcoRI-BamHI fragment and the 2.7 kbp BamHI-XbaI fragment. The cell lines with different combinations of deglycosylation mutations are listed in Table 1 below.
Constructs for producing the soluble secreted ectodomain of the mutant receptor were made with an SspI cleavage site located 9 nt upstream of the encoded transmembrane region in hIR cDNA [8, 9] . The presence of several SspI sites in plasmid pEE14 necessitated a three-way ligation involving (1) the larger XbaIBamHI fragment from the expression vehicle of mutant receptors (which included the entire pEE14 expression vector sequence with the encoded hIR sequence to residue 599), (2) a BamHI-SspI fragment of hIR cDNA encoding residues 600-914 and harbouring mutations at residues 730, 743 and 881, and (3) a small synthetic oligonucleotide linker encoding an in-frame translation stop signal [22] to join the SspI and XbaI termini.
Transfection and screening
For transient transfection assays, 293T cells were grown in Dulbecco's modified Eagle's medium (Gibco BRL, Gaithersburg, MD, U.S.A.) plus 10 % (v\v) foetal calf serum, to 50-80 % confluence, and were then transfected with plasmid DNA with FuGENE (Roche Molecular Biochemicals) in accordance with the manufacturer's instructions. Cells were cultured for 2 days before serum starvation overnight and subsequent use.
Stable cell lines were prepared in CHO-K1 and Lec8 cells as follows. Cells were grown to between 50 % and 80 % confluence in minimum essential medium α medium (Gibco BRL) including 2 mM glutamine and 10 % (v\v) foetal calf serum before transfection with DNA-liposome complexes prepared with Lipofectamine (Gibco BRL). After cell recovery and exchange of media to glutamine-free Glasgow's modified Eagle's medium (ICN Biomedicals, Costa Mesa, CA, U.S.A.) plus 10 % (v\v) dialysed foetal calf serum, cells were selected with 25 µM methionine sulphoximine (Sigma). This inhibitor of glutamine synthase prevents the growth of cells not harbouring multiple copies of the glutamine synthase minigene from plasmid pEE14 [38] . Colonies (or supernatant for ectodomain constructs) were screened for protein expression by ELISA. Cell lines expressing a high level of receptor were selected by FACS and were cloned by limiting dilution. The ELISA employed anti-(insulin receptor) monoclonal antibody (mAb) 83.7 as the capture antibody and biotin-labelled mAb 83.14 for detection [39] . In FACS analysis, cells were treated with mAb 83.7 followed by FITC-labelled antimouse secondary antibody from sheep.
Metabolic labelling
Subconfluent cells were washed and incubated for 30 min in methionine\cysteine-free Dulbecco's modified Eagle's medium and then labelled by growth overnight in the presence of 5 µl (50 µCi) of methionine\cysteine Tran$&S-label (ICN Biomedicals). Cells were collected and solubilized by the method of Lammers et al. [40] and hIR from the lysate was immunoprecipitated with mAb 83.14 (4 µg) and Protein A-Sepharose (Sigma) slurry (20 µl). Immunoprecipitates were washed, boiled in Laemmli sample buffer under reducing conditions [41] and analysed by SDS\PAGE. Gels were fixed and soaked in Amplify Insulin receptor glycosylation-site mutants
Figure 1 Distribution of potential N-linked glycosylation sites in hIR, hIGF-1R and hIRR ectodomains
Residue numbers of the potential N-linked glycosylation sites in hIR, hIGF-1R and hIRR are shown above the diagram of the structural modules that make up the hIR ectodomain. There are two isoforms of the hIR that differ in the presence or absence of 12 amino acid residues coded for by exon 11. The glycosylation site at 730 in hIRR (marked with an asterisk) occurs in a similar location to hIGF-1R 717 and hIR 730. This region of hIRR shows negligible sequence similarity to the other two receptors. (Amersham, Little Chalfont, Bucks., UK) before being dried and subjected to autoradiography. X-ray films were scanned with a Gel-Pro Analyser, version 3 (Media Cybernetics, Silver Spring, MD, U.S.A.).
Autophosphorylation
A simple immunoblotting assay for comparing the relative levels of receptor autophosphorylation was employed with stable CHO cell lines and transiently transfected 293T cells. Subconfluent cells were deprived of serum overnight and then incubated in the presence or absence of insulin (100 nM) for 10 min. Receptor from cells was prepared as above in the presence of Na $ VO % (1 mM) to inhibit phosphatases, then fractionated by SDS\ PAGE and transferred to nitrocellulose membrane. Phosphorylated β subunit was detected by probing with anti-phosphotyrosine antibody (PY 20) conjugated to horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), followed by SuperSignal4 chemiluminescent substrate (Pierce, Rockford, IL, U.S.A.) and exposure to Hyperfilm4 (Amersham). Films were scanned with a Gel-Pro Analyser, version 3 (Media Cybernetics). To demonstrate comparable receptor levels in assays, the membrane was stripped of antibody and reprobed with an antibody against hIR β chain (mAb CT-1), followed by an anti-(mouse IgG) antibody conjugated to horseradish peroxidase for detection (Santa Cruz Biotechnology).
Insulin binding
To assess the affinity for insulin of mutagenized receptors, the binding of "#&I-insulin (Dupont NEN, Boston, MA, U.S.A.) was examined over a range of unlabelled insulin concentrations in a solid-phase assay with mAb immobilized on microtitre plates to capture detergent-released insulin receptor or soluble, secreted ectodomain [42] . Insulin bound to receptor was determined, after extensive washing, by counting γ radioactivity. Results were collated and analysed with the LIGAND program [43] and plotted on Scatchard coordinates [44] . Binding constants represent the means for three experimental determinations for mutants and eight for the CHO.T control cell line, which overexpresses wild-type hIR [34] . A statistical comparison of groups of experimental values was performed with Student's t test.
Ectodomain purification and characterization
Ectodomain from large-scale fermentation of Lec8 cells was recovered from medium as a soluble protein by affinity chromatography on a bis-(t-butoxycarbonyl)insulin column and further purified to remove oligomers and cleavage products by gel filtration on a Superdex 200 HR 10\30 column (Pharmacia), essentially as described previously [16, 22] . The molecular mass of ectodomain from Lec8 cells was determined by ultracentrifugation, assuming the same partial specific volumes of carbohydrate and protein as used previously for the molecular mass determination of CHO-K1-derived ectodomain [22] . Ectodomain proteins were compared before and after treatment with neuraminidase by SDS\PAGE and by isoelectric focusing in Novex (San Diego, CA, U.S.A.) pH 3-7 polyacrylamide gel. Gels were fixed, stained and destained in accordance with the manufacturer's instructions. Neuraminidase from avian N9 influenza virus [22] was used at an enzyme-to-substrate ratio of 1 : 100 in phosphate buffer, pH 7.0, at 37 mC for 2 h.
RESULTS

Whole hIR mutants
The locations of the potential N-linked glycosylation sites are shown schematically in Figure 1 . Of the 18 sites in hIR, 15 were mutated in different combinations. The exceptions were the sites at 25, 397 and 894, which have previously been shown to be important for hIR biosynthesis or function [26, 31, 32] . These three sites, along with five others, are conserved in hIGF-1R and hIRR ( Figure 1) .
The 16 stable CHO-K1 cell lines expressing intact hIR with various combinations of glycosylation sites removed are listed in Table 1 . Cell-surface expression was monitored by FACS analysis with mAb 83.7 [39] . All except one of the stable cell lines showed increases in fluorescence of more than 18-fold that of the parental CHO-K1 cell line ( Figure 2 ) and comparable with that of the CHO.T cell line (Table 1) , which produces more than 250 000 insulin receptors per cell [34] . The one exception was the ∆3a mutant (N"' , #"&,#&&Q), which was poorly transported to the cell surface. The increase in fluorescence for this cell line was approx. 3.5-fold (Figure 2) . Analysis of mutant receptors by metabolic labelling and SDS\PAGE showed the characteristic pattern of proreceptor, α chain and β chain consistent with normal receptor processing, for all cell lines except ∆7b (Table 1, Figure 3 ) and ∆3a (results not shown). Both produced mainly uncleaved proreceptor (Figures 3 and 4) , despite the large difference in cell-surface expression levels discussed above. The amounts of correctly cleaved ∆3a and ∆7b, after transient expression in 293T cells, were 4 % and negligible respectively, as judged by densitometric scanning of Western blots ( Figure 4B ). The amount of correctly cleaved ∆7b when expressed in CHO-K1 cells ranged from 15 % to 25 % as judged by densitometric scanning of autoradiographs of metabolically labelled receptor ( Figure 3 ). As expected, the α and β chains of mutant receptors showed smaller apparent molecular masses than wild-type receptor subunits, particularly for the higher-order mutants (Figure 3) . In insulin binding studies, most of the 16 mutated receptors bound insulin with a high affinity that did not differ significantly from that of the wild-type receptor expressed by the CHO.T cell Insulin receptor glycosylation-site mutants line (Table 1 ). The exceptions were mutant ∆3d, which exhibited a marginally lower binding affinity (P l 0.06), and mutant ∆3a, which showed negligible insulin binding owing to the low level of surface expression of processed receptor (Figure 2 ). Although stable cell lines of mutant ∆7b bound sufficient insulin to determine the binding affinity (Table 1) , 293T cells transiently transfected with ∆7b showed negligible binding relative to cells transfected with wild-type hIR. This suggests that only the small amount of fully processed ∆7b receptor in the stable cell lines could bind insulin. All mutant receptors, which bound sufficient insulin for data collection (i.e. all except ∆3a), showed concave curvilinearity in Scatchard plots at supraphysiological concentrations of insulin [42] .
Figure 3 SDS/PAGE analysis of reduced, metabolically labelled insulin receptor mutants expressed in CHO-K1 cells
In all mutant cell lines except ∆3a, ∆4b and ∆7b, stimulation of receptor autophosphorylation with insulin was comparable with that of wild-type receptor from CHO.T as judged by β-chain phosphorylation (Table 1) . Photographic exposure times, which detected a very low signal in basal level autophosphorylation (1.9-2.7 % of the insulin-stimulated signal), showed strong signals after stimulation with insulin ( Figure 4 ). The ∆4b mutant was constitutively active, showing a high basal level of activity that did not increase after stimulation with insulin ( Figure 4) . Although the levels of processed receptor on the cell surface of mutant ∆3a were low, the receptor nevertheless seemed to display normal insulin-induced autophosphorylation (Figure 4) . The ∆7b mutant, which was expressed at high levels on the cell surface, displayed negligible proreceptor processing or insulininduced autophosphorylation signal (Figure 4) . When longer exposure times were used, autophosphorylation of ∆7b was restricted to the small amount of processed receptor.
Secreted hIR ectodomains
The ∆6 and ∆7a mutations were incorporated into constructs for expression as soluble, secreted ectodomains in both CHO-K1 cells and the Lec8 mutant of CHO-K1 cells, which produce Nlinked oligosaccharides lacking terminal galactose and N-acetylneuraminic acid residues. Wild-type ectodomain produced in Lec8 cells showed normal processing into α and truncated β subunits (βh) with decreased apparent molecular masses on SDS\PAGE relative to the corresponding ectodomain produced in CHO-K1 cells ( Figure 5, lanes 1-3 and 4-6 ). Analytical ultracentrifugation of purified wild-type ectodomain indicated a decrease in molecular mass of ectodomain from 270 kDa in CHO-K1 cells [22] to 240 kDa in Lec8 cells and a further decrease to 230 kDa for the ectodomain of mutant ∆6.
The Lec8-expressed hIR ectodomain showed little difference in insulin binding relative to the corresponding ectodomain from CHO-K1 cells (Table 1) ; all ectodomain preparations had linear Scatchard plots for insulin binding. Insulin affinity was higher (P 0.05) for the ectodomain of glycosylation-site mutants than for unmodified ectodomain (Table 1) .
Large-scale fermentations of Lec8 cells yielded 2-3 mg\l of ectodomain from wild-type receptor or from the mutant ∆6 as estimated by amino acid analysis, with 90 % of the product recovered by affinity chromatography [16, 22] as estimated by ELISA. A comparison of charge heterogeneity between these products and the ectodomain from CHO-K1 cells was made by 
Figure 6 Isoelectric focusing of ectodomain preparations in polyacrylamide gel (5 %, w/w)
Insulin receptor ectodomain protein was produced by large-scale fermentation of transfected CHO-K1 or Lec8 cells and purified by insulin-affinity chromatography and gel filtration as described in the Materials and methods section. Aliquots (5-10 µg in 15 µl) were mixed with 15 µl of sample buffer and subjected to isoelectric focusing in pH 3-7 polyacrylamide gels. isoelectric focusing (Figure 6 ). Wild-type ectodomain from CHO-K1 cells revealed a pattern of multiple, closely spaced isoforms ranging from pI 4.0 to 4.5, considerably more acidic than the pI estimated from the amino acid composition, reflecting the presence of variable end-capped sialylation expected in CHO-K1 cells. Isoelectric focusing of Lec8-derived, wild-type ectodomain showed isoforms of higher pH range from pI 5.25 to 5.6. Neuraminidase treatment of the wild-type ectodomain produced in CHO-K1 cells transposed the pI range to higher pH values, similar to that seen with the Lec8-derived product. The ∆6 mutant from Lec8 cells produced isoforms over a narrower range, from pI 5.45 to 5.65. Treatment with neuraminidase produced no detectable change in this pattern ( Figure 6 ).
DISCUSSION
Studies aimed at elucidating the steps involved in the expression, folding and assembly of the mature insulin receptor homodimer have been reviewed recently [45] . Glycosylation is critical for insulin receptor biosynthesis. Inhibition of N-linked glycosylation by tunicamycin leads to the intracellular accumulation of aglyco-proreceptors, which fail to form correctly assembled tertiary and quaternary structures [46] . The lectin chaperones calnexin and calreticulin, together with the heat-shock protein 70 analogue BiP, control the folding of proteins in the endoplasmic reticulum (ER) [3] . Calreticulin, and to a smaller extent calnexin, have been shown to associate with both the early monomeric and late monomeric proreceptor species of insulin receptor but not with the insulin receptor dimers [5] . This suggests that once the insulin receptor monomers have been correctly folded these lectin chaperones no longer bind, permitting receptor dimerization followed by export from the ER. When calnexin and calreticulin binding is blocked by castanospermine, insulin receptor dimerization is accelerated but the receptor protein is retained in the ER through interactions with BiP until it is correctly folded and transported to the trans-Golgi [5] . The ability to form functional receptors in the absence of ER lectin binding but not in the absence of glycosylation indicates that Nlinked carbohydrate also functions to enhance the solubility of insulin receptor and to counteract aggregate formation [47] .
In this study we have investigated the effects of removing N-linked glycosylation sites from various regions of the hIR. The effects of these mutations are summarized in Table 1 and the comparative data for other glycosylation site mutations are summarized in Table 2 . These studies indicate that there are many redundancies in hIR glycosylation sites and that every site can be mutated individually without detriment to cell-surface expression, receptor processing and ligand binding. When combinations of sites are examined, it seems that major domains of the receptor, particularly those closer to the N-terminus (i.e. L1, Cys-rich, L2), require at least one intact glycosylation site to ensure correct folding and processing. In the studies of the effects of the removal of different glycosylation sites on the folding and assembly of influenza virus HA, it was concluded that specific glycosylation sites, particularly those that are distal to the membrane surface, are important to allow these protein domains to be sequestered by calreticulin and calnexin until polypeptide synthesis is complete [4] . These distal sites in HA were bound preferentially by calreticulin, which, unlike calnexin, is not membrane-bound. Interestingly, much more of the hIR proreceptor in the ER was found to be associated with calreticulin than with calnexin [5] .
Removal of the four glycosylation sites in the N-terminal L1 domain (at residues 16, 25, 78 and 111) resulted in the complete retention of proreceptor in the ER and no proreceptor processing [30, 31, 48] . The mutant proreceptor was a dimer and could bind insulin, but failed to show insulin-induced kinase activity in itro [48] . Of the four sites, that at residue 25, which is conserved in all three members of the insulin receptor family (Figure 1 ), seems to be the most important. The double mutant at 16 and 25 and the triple mutant 25, 78 and 111 were severely compromised in terms of processing and cell-surface expression (Table 2) , although the receptor that is processed binds and autophosphorylates normally [31] . The triple mutant 16, 78 and 111 and the double [26, 29] mutant 78 and 111 were not as severely affected [31] . The two L1-domain double mutants 16 and 78 (∆2a) and 16 and 111 (∆2b) examined in this study were processed normally (Table 1 ).
In the Cys-rich domain, none of the three sites (residues 215, 255 and 295) seem to be critical individually. The double mutants ∆2c (16j215) and ∆2d (16j255) were normal, as were the triple and higher-order mutants ∆3b, ∆3c and ∆7a, which lacked the conserved site at residue 295 ( Table 1 ). The triple mutant ∆3a (16j215j255), from which the first two sites in the Cys-rich domain were removed along with residue 16, was poorly transported to the cell surface and little processed receptor was produced. The three-dimensional structure of the L1-Cys-rich-L2 region of the IGF-1R shows that residues 215 and 255 are located in a region of the Cys-rich domain that is in intimate contact with the L1 domain [15] . It seems that at least one Nlinked oligosaccharide moiety is required in this region of the receptor for efficient folding to take place. Although there was insufficient ∆3a receptor to measure insulin binding directly, indirect evidence for insulin binding (by the small amount of processed receptor) came from the observation of insulin-induced autophosphorylation ( Figure 4A ).
There are three glycosylation sites in the L2 domain of the hIR (337, 397 and 418), one of which (residue 397) is conserved in hIGF-1R and hIRR (Figure 1 ). The simultaneous removal of two of these sites, residues 397 and 418, has been shown to affect receptor biosynthesis severely, whereas the individual mutation of either of these sites was without detrimental effect [32] , as summarized in Table 2 . The three-dimensional structure of the L1-Cys-rich-L2 domain fragment of hIGF-1R suggests, by homology, that both of these residues are located on the same face of the hIR L2 domain [15] . In the present study we have retained the site at residue 397 and shown that mutants lacking both 337 and 418 (∆2e) are normal, as are the higher-order mutants ∆3b, ∆3d, ∆6 and ∆7a, which also lack this pair of L2 glycosylation sites (Table 1) .
The single N-linked site (residue 514) in the first FnIII domain of the hIR is predicted to lie in the C-Ch loop at the base of this module [17] [18] [19] . Of the mutants lacking this site, mutant ∆3c seemed to be normal, whereas mutant ∆3d seemed normal except for a marginally lower insulin binding affinity (Table 1) . This lower insulin binding affinity might be related to the fact that the three glycosylation sites (residues 337, 418 and 514) are located within a region (residues 325-524) that has been suggested to be a major determinant of high-affinity insulin binding [49] . Labelled insulin has been shown to associate with receptor sequence in this region [50] . The higher-order mutant ∆7b, which also included the 514 mutation, was not cleaved into α and β subunits, in contrast with mutants ∆6 and ∆7a, with which ∆7b shared six mutations (residues 16, 337, 418, 730, 743 and 881).
The four N-linked glycans of the β chain (at residues 742, 755, 893 and 906 in the exon 11 + isoform) can be removed simultaneously without affecting proreceptor processing, surface expression or insulin binding [29] . However, this mutant was defective in autophosphorylation and kinase activity and was unable to transduce the signals for glycogen or DNA synthesis [26, 29] . Analysis of single-site and double-site mutations established that this signalling defect was caused predominantly by the mutation at residue 906, although removal of the site at N)*$ also depressed kinase activity by 40 % [26, 29] . In our studies with the exon 11 − isoform, removal of the first three N-glycosylation sites in the β chain had no effect on cell-surface expression, processing, insulin binding or autophosphorylation. These three mutations could be combined with removal of the site at either 606 (mutant ∆4a) or 671 (mutant ∆4c) or the multiple mutations at 16, 337, 418 (mutant ∆6) or 16, 295, 337, 418 (mutant ∆7a), without significantly affecting cell-surface expression, processing, insulin binding or autophosphorylation (Table 1 ). In contrast, the quadruple mutant ∆4b (sites 624, 730, 742, 881) showed normal processing and ligand binding, but was constitutively active as judged by autophosphorylation.
In this study we have expanded on previous results and have shown that for hIR, six or seven (39 %) of the potential N-linked glycosylation sites can be removed without apparent detriment to surface expression, processing and insulin binding. Potential for further decrease in the number of sites might exist provided that the carbohydrate remaining can fulfil all functions required in the cell, and solubility is not compromised at the high protein concentrations required for crystallization. Among the other remaining sites, residues 255 and 671 have no equivalent counterparts in either hIRR or hIGF-1R, suggesting that these sites might be suitable candidates for the more extensive elimination of glycosylation sites from hIR.
One of the major factors affecting the successful crystallization of proteins is the extent and heterogeneity of glycosylation [1, 2] . The ectodomain of the insulin receptor has been produced previously as a soluble secreted protein in CHO-K1 cells and shown to contain 58-64 kDa of attached carbohydrate on the basis of a calculated apoprotein molecular mass of 209 kDa [22] . To decrease charge heterogeneity from partial sialylation and to lower oligosaccharide content, the production of ectodomain was examined in the Lec8 mutant CHO-K1 cell line, which has a defect in glycosylation [33] . Ultracentrifugation showed that the amount of attached carbohydrate on the Lec8-produced hIR ectodomain had been decreased to 30-32 kDa [16] . The carbohydrate content of ectodomain in the ∆6 mutant produced in Lec8 cells had been further decreased to 20-22 kDa, which is approximately one-third of the level present in the wild-type ectodomain expressed in the CHO-K1 cell line. This residual carbohydrate represents approx. 10 % of the molecular mass of ectodomain, a level accordant with those of glycoproteins whose structures have been determined by X-ray diffraction. Ectodomain from this ∆6 mutant has not been compromised in biosynthesis or insulin binding relative to unmodified ectodomain and remains soluble at high protein concentration. It offers the possibility of a protein that might be more amenable to crystallization and diffraction studies than the wild-type ectodomain.
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